...
首页> 外文期刊>Current medical research and opinion >Secondary exposure to testosterone from patients receiving replacement therapy with transdermal testosterone gels
【24h】

Secondary exposure to testosterone from patients receiving replacement therapy with transdermal testosterone gels

机译:接受经皮睾丸激素凝胶替代治疗的患者的睾丸激素二次暴露

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The potential for unintended transfer of testosterone to others from adult men receiving transdermal testosterone gel treatment for hypogonadism is a recognized safety concern, due to the undesirable pharmacologic effects of testosterone in women and children1,2. The following three papers present the results from five phase 1 studies that investigated the transfer of testosterone to adult women from male partners who applied a 1.62% testosterone gel (AndroGel 1.62%, Abbott)3–5. Read More: http://informahealthcare.com/doi/full/10.1185/03007995.2011.652255
机译:由于睾丸激素对妇女和儿童的不良药理作用,从接受透皮睾丸激素凝胶治疗性腺功能减退的成年男性中意外转移睾丸激素的潜力是公认的安全性问题1,2。以下三篇论文介绍了五项1期研究的结果,这些研究调查了使用1.62%睾丸激素凝胶(AndroGel 1.62%,Abbott)3-5的男性伴侣向成年女性转移睾丸激素的过程。了解更多:http://informahealthcare.com/doi/full/10.1185/03007995.2011.652255

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号